Johnson Investment Counsel’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3,395	Closed	-$349K	–	642
2018 Q1	$349K	Sell	3,395 -37	-1%	-$3.8K	0.01%	495
2017 Q4	$293K	Buy	3,432 +71	+2%	+$6.06K	0.01%	527
2017 Q3	$285K	Hold	3,361	–	–	0.01%	521
2017 Q2	$254K	Buy	+3,361	New	+$254K	0.01%	544